{"mainPropery":{"diseaseId":9265,"diseaseName":"Glucose transporter type 1 deficiency syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9265/glucose-transporter-type-1-deficiency-syndrome","synonyms":["GLUT1 deficiency syndrome","Encephalopathy due to GLUT1 deficiency","Glucose transport defect, blood-brain barrier","De Vivo disease","GLUT-1 deficiency syndrome","Glucose transporter protein syndrome","GLUT1 DS","G1D"],"synonyms-with-source":[{"name":"GLUT1 deficiency syndrome"},{"name":"Encephalopathy due to GLUT1 deficiency"},{"name":"Glucose transport defect, blood-brain barrier"},{"name":"De Vivo disease"},{"name":"GLUT-1 deficiency syndrome"},{"name":"Glucose transporter protein syndrome"},{"name":"GLUT1 DS"},{"name":"G1D","source":"GHR"}],"identifiers":[{"identifierType":"OMIM","identifierId":"606777"},{"identifierType":"ORPHANET","identifierId":"71277"},{"identifierType":"UMLS","identifierId":"C1847501"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":2522,"resourceName":"Glut1 Deficiency Foundation","abbreviation":"","address1":"P.O. Box 737 ","address2":"","address3":"","address4":"","address5":"","city":"Owingsville","state":"KY","zip":"40360","country":"United States","phone":"","tty":"","tollFree":"","fax":"","email":"info@g1dfoundation.org","url":"https://www.g1dfoundation.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/606777' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=((glut1+deficiency+syndrome[TIAB])+OR+(glucose+transporter+protein+syndrome[TIAB])+OR+(glucose+transporter+type+1+deficiency+syndrome[TIAB]))+AND+english[la]+AND+human[mh]+AND+\"last+2520+days\"[dp]' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Glucose transporter type 1 deficiency syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='https://www.clinicaltrials.gov/ct2/results?cond=GLUT1%20DEFICIENCY%20SYNDROME%20' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Glucose transporter type 1 deficiency syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/glut1-deficiency-syndrome' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Glucose transporter type 1 deficiency syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":336,"resourceId":1154,"resourceName":"RareConnect","descriptionText":"<div style=\"margin-top: 0px; margin-bottom: 0px;\"><a href='https://www.rareconnect.org/en/community/glut1-ds' target='_blank'>RareConnect</a> has an online community for patients&nbsp;and families with this condition so they can connect with others and share&nbsp;their experiences living with a rare disease.&nbsp;The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders).</div>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1847501' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/glucose-transporter-type-1-deficiency-syndrome/ ' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=71277' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1430/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_BIMDG_GLUT1Deficiency-enPro10999.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:606777' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":9794,"questionText":"What is glucose transporter type 1 deficiency syndrome?","answerText":"<strong>Glucose transporter type 1 deficiency syndrome</strong> (GLUT1 deficiency syndrome) is an inherited condition that affects the nervous system. Signs and symptoms generally develop within the first few months of life and may include recurrent <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003200.htm\" tabindex=\"-1\" target=\"_blank\">seizures</a> (epilepsy) and involuntary eye movements. Affected people may also have microcephaly (unusually small head size) that develops after birth, developmental delay, intellectual disability and other neurological problems such as <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003297.htm\" tabindex=\"-1\" target=\"_blank\">spasticity</a>, ataxia (difficulty coordinating movements), and <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/007470.htm\" tabindex=\"-1\" target=\"_blank\">dysarthria</a>. Approximately 10% of affected people have the \"non-epileptic\" form of GLUT1 deficiency syndrome which is associated with all the typical symptoms of the condition without seizures.[10169][10171] GLUT1 deficiency syndrome is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <em><a href=\"http://ghr.nlm.nih.gov/gene/SLC2A1\" target=\"_blank\">SLC2A1</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> manner. Although there is currently no cure for GLUT1 deficiency syndrome, a special diet (called a <a href=\"http://www.g1dfoundation.org/what-is-glut1-deficiency/about-the-ketogenic-diet/\" tabindex=\"-1\" target=\"_blank\">ketogenic diet</a>) may help alleviate symptoms.[10170]","dateModified":"2015-12-07T15:43:00"},"basicQuestions":[{"questionId":9802,"questionText":"What are the signs and symptoms of glucose transporter type 1 deficiency syndrome?","answerText":"The most common form of glucose transporter type 1 deficiency syndrome (GLUT1 deficiency syndrome), called the classic type, may be characterized by:[10169][10170][10171]\r\n<ul>\r\n    <li>Recurrent seizures (epilepsy) beginning in the first months of life</li>\r\n    <li>Microcephaly (unusually small head size) that develops after birth</li>\r\n    <li>Developmental delay</li>\r\n    <li>Intellectual disability</li>\r\n    <li>Speech and language impairment</li>\r\n    <li>Movement abnormalities (i.e. involuntary eye movements, <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003297.htm\" tabindex=\"-1\" target=\"_blank\">spasticity</a>, ataxia, <a href=\"https://www.nlm.nih.gov/medlineplus/dystonia.html\" tabindex=\"-1\" target=\"_blank\">dystonia</a>)</li>\r\n    <li>Behavioral problems</li>\r\n</ul>\r\nOther signs and symptoms may include headaches, confusion, loss of energy and/or myoclonus (muscle twitches).[10169]<br />\r\n<br />\r\nApproximately 10% of affected people have the non-epileptic form of GLUT1 deficiency syndrome. This form is associated with all the typical symptoms of the condition without seizures.[10169][10170]","dateModified":"2015-12-08T14:21:00","resourceClassificationName":"Symptoms","references":[{"referenceId":10169,"authors":"","articleTitle":"GLUT1 deficiency syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/glut1-deficiency-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10170,"authors":"Dong Wang, MD, Juan M Pascual, MD, PhD, and Darryl De Vivo, MD","articleTitle":"Glucose Transporter Type 1 Deficiency Syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"January 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1430/#glut1.Clinical_Description","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10171,"authors":"","articleTitle":"Glucose Transporter Type 1 Deficiency Syndrome","bookWebsiteJournalTitle":"NORD","date":"2014","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/glucose-transporter-type-1-deficiency-syndrome/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9795,"questionText":"What&nbsp;causes glucose transporter type 1 deficiency syndrome?","answerText":"Glucose transporter type 1 deficiency syndrome (GLUT1 deficiency syndrome) is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>) in the <a href=\"http://ghr.nlm.nih.gov/gene/SLC2A1\" tabindex=\"-1\" target=\"_blank\"><em>SLC2A1</em></a> gene. This gene encodes a protein that helps transport glucose (a simple sugar) into cells where it is used as fuel. The protein is particularly important in the central nervous system since glucose is the brain's main source of energy. <em>SLC2A1</em> mutations impair the function of the protein. This significantly reduces the amount of glucose available to brain cells leading to the many signs and symptoms associated with GLUT1 deficiency syndrome.[10169][10172]","dateModified":"2015-12-07T19:52:00","resourceClassificationName":"Cause","references":[{"referenceId":10169,"authors":"","articleTitle":"GLUT1 deficiency syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/glut1-deficiency-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10172,"authors":"","articleTitle":"What is Glut1 Deficiency?","bookWebsiteJournalTitle":"GLUT1 Deficiency Foundation","date":"","volume":"","pages":"","url":"http://www.g1dfoundation.org/what-is-glut1-deficiency/what-is-glut1-deficiency/","dateAccessed":"2015-12-07T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9803,"questionText":"Is glucose transporter type 1 deficiency syndrome inherited?","answerText":"Glucose transporter type 1 deficiency syndrome (GLUT1 deficiency syndrome) is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" tabindex=\"-1\" target=\"_blank\">autosomal dominant</a>  manner.[10169] This means that to be affected, a person only needs a change (<a href=\"http://www.genome.gov/glossary/index.cfm?id=134\" tabindex=\"-1\" target=\"_blank\">mutation</a>) in one copy of the responsible <a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" tabindex=\"-1\" target=\"_blank\">gene</a> in each cell. In some cases, an affected person inherits the mutation from an affected parent. Other cases may result from new (<em></em><a href=\"http://www.ghr.nlm.nih.gov/glossary=denovomutation\" tabindex=\"-1\" target=\"_blank\">de novo</a>) mutations in the gene. These cases occur in people with no history of the disorder in their family. A person with GLUT1 deficiency syndrome has a 50% chance with each pregnancy of passing along the altered gene to his or her child.","dateModified":"2015-12-08T14:30:00","resourceClassificationName":"Inheritance","references":[{"referenceId":10169,"authors":"","articleTitle":"GLUT1 deficiency syndrome","bookWebsiteJournalTitle":"Genetics Home Reference","date":"March 2014","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/glut1-deficiency-syndrome","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9804,"questionText":"How is glucose transporter type 1 deficiency syndrome diagnosed?","answerText":"A diagnosis of glucose transporter type 1 deficiency syndrome (GLUT1 deficiency syndrome) is often suspected based on the presence of characteristic <a href=\"https://rarediseases.info.nih.gov/gard/9265/glucose-transporter-type-1-deficiency-syndrome/resources/9\" tabindex=\"-1\" target=\"_blank\">signs and symptoms</a>. Additional testing can then be ordered to confirm the diagnosis. This may include a <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003428.htm\" tabindex=\"-1\" target=\"_blank\">lumbar puncture</a>, specialized blood tests to measure the blood concentration of glucose and genetic testing.[10170][10171]","dateModified":"2015-12-08T14:53:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":10170,"authors":"Dong Wang, MD, Juan M Pascual, MD, PhD, and Darryl De Vivo, MD","articleTitle":"Glucose Transporter Type 1 Deficiency Syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"January 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1430/#glut1.Clinical_Description","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10171,"authors":"","articleTitle":"Glucose Transporter Type 1 Deficiency Syndrome","bookWebsiteJournalTitle":"NORD","date":"2014","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/glucose-transporter-type-1-deficiency-syndrome/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":9805,"questionText":"How might glucose transporter type 1 deficiency syndrome be treated?","answerText":"There is currently no cure for glucose transporter type 1 deficiency syndrome (GLUT1 deficiency syndrome); however, a special diet (called a ketogenic diet) may help control symptoms in some affected people.[10170] The <a href=\"http://www.g1dfoundation.org/what-is-glut1-deficiency/about-the-ketogenic-diet/\" tabindex=\"-1\" target=\"_blank\">GLUT1 Deficiency Foundation</a> offers&nbsp;an information page with detailed information regarding the ketogenic diet. Please click on the link to access this resource. &nbsp;&nbsp;&nbsp;&nbsp;","dateModified":"2015-12-08T14:58:00","resourceClassificationName":"Treatment","references":[{"referenceId":10170,"authors":"Dong Wang, MD, Juan M Pascual, MD, PhD, and Darryl De Vivo, MD","articleTitle":"Glucose Transporter Type 1 Deficiency Syndrome","bookWebsiteJournalTitle":"GeneReviews","date":"January 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1430/#glut1.Clinical_Description","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":15516,"phenoTypeName":"Abnormal erythrocyte morphology","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9421,"phenoTypeName":"Dystonia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11431,"phenoTypeName":"EEG abnormality","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9387,"phenoTypeName":"Encephalopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13243,"phenoTypeName":"Hypoglycorrhachia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9837,"phenoTypeName":"Progressive microcephaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8711,"phenoTypeName":"Spasticity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13751,"phenoTypeName":"Status epilepticus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8726,"phenoTypeName":"Choreoathetosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9380,"phenoTypeName":"Confusion","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10281,"phenoTypeName":"Cyanosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14142,"phenoTypeName":"Delayed speech and language development","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10830,"phenoTypeName":"Extrapyramidal dyskinesia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3542,"phenoTypeName":"Generalized hyperreflexia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8728,"phenoTypeName":"Hemiparesis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8721,"phenoTypeName":"Lethargy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6236,"phenoTypeName":"Muscle stiffness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13591,"phenoTypeName":"Paralysis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10565,"phenoTypeName":"Paroxysmal involuntary eye movements","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13858,"phenoTypeName":"Apraxia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7961,"phenoTypeName":"Central apnea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10639,"phenoTypeName":"Myoclonus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11439,"phenoTypeName":"Sleep disturbance","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10498,"phenoTypeName":"Strabismus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13037,"phenoTypeName":"Abnormality of metabolism/homeostasis","percentRanges":"-"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":13598,"phenoTypeName":"Babinski sign","percentRanges":"-"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":11223,"phenoTypeName":"Paroxysmal dystonia","percentRanges":"-"},{"phenoTypeId":13244,"phenoTypeName":"Paroxysmal lethargy","percentRanges":"-"},{"phenoTypeId":9533,"phenoTypeName":"Postnatal microcephaly","percentRanges":"-"},{"phenoTypeId":9417,"phenoTypeName":"Specific learning disability","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Glucose_transporter_type_1_deficiency_syndrome"}